These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 20451671

  • 1. Thermodynamic study of the BRCT domain of BARD1 and its interaction with the -pSER-X-X-Phe- motif-containing BRIP1 peptide.
    Thanassoulas A, Nomikos M, Theodoridou M, Yannoukakos D, Mastellos D, Nounesis G.
    Biochim Biophys Acta; 2010 Sep; 1804(9):1908-16. PubMed ID: 20451671
    [Abstract] [Full Text] [Related]

  • 2. The BARD1 C-terminal domain structure and interactions with polyadenylation factor CstF-50.
    Edwards RA, Lee MS, Tsutakawa SE, Williams RS, Nazeer I, Kleiman FE, Tainer JA, Glover JN.
    Biochemistry; 2008 Nov 04; 47(44):11446-56. PubMed ID: 18842000
    [Abstract] [Full Text] [Related]

  • 3. Thermal and chemical denaturation of the BRCT functional module of human 53BP1.
    Thanassoulas A, Nomikos M, Theodoridou M, Stavros P, Mastellos D, Nounesis G.
    Int J Biol Macromol; 2011 Oct 01; 49(3):297-304. PubMed ID: 21600917
    [Abstract] [Full Text] [Related]

  • 4. Multimodal approach to explore the pathogenicity of BARD1, ARG 658 CYS, and ILE 738 VAL mutants.
    Choudhary RK, Vikrant, Siddiqui QM, Thapa PS, Raikundalia S, Gadewal N, Kumar NS, Hosur MV, Varma AK.
    J Biomol Struct Dyn; 2016 Jul 01; 34(7):1533-44. PubMed ID: 26307947
    [Abstract] [Full Text] [Related]

  • 5. Crystal structure of the BARD1 BRCT domains.
    Birrane G, Varma AK, Soni A, Ladias JA.
    Biochemistry; 2007 Jul 03; 46(26):7706-12. PubMed ID: 17550235
    [Abstract] [Full Text] [Related]

  • 6. Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair.
    Laufer M, Nandula SV, Modi AP, Wang S, Jasin M, Murty VV, Ludwig T, Baer R.
    J Biol Chem; 2007 Nov 23; 282(47):34325-33. PubMed ID: 17848578
    [Abstract] [Full Text] [Related]

  • 7. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E, Irminger-Finger I.
    Int J Biochem Cell Biol; 2010 May 23; 42(5):693-700. PubMed ID: 20060929
    [Abstract] [Full Text] [Related]

  • 8. Structural basis to stabilize the domain motion of BARD1-ARD BRCT by CstF50.
    Choudhary RK, Siddiqui MQ, Thapa PS, Gadewal N, Nachimuthu SK, Varma AK.
    Sci Rep; 2017 Jun 20; 7(1):3849. PubMed ID: 28634376
    [Abstract] [Full Text] [Related]

  • 9. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
    Liu X, Ladias JA.
    Biochemistry; 2013 Oct 29; 52(43):7618-27. PubMed ID: 24073851
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.
    Tembe V, Martino-Echarri E, Marzec KA, Mok MT, Brodie KM, Mills K, Lei Y, DeFazio A, Rizos H, Kettle E, Boadle R, Henderson BR.
    Cell Signal; 2015 Sep 29; 27(9):1763-71. PubMed ID: 26022179
    [Abstract] [Full Text] [Related]

  • 12. BRCA1 DNA-binding activity is stimulated by BARD1.
    Simons AM, Horwitz AA, Starita LM, Griffin K, Williams RS, Glover JN, Parvin JD.
    Cancer Res; 2006 Feb 15; 66(4):2012-8. PubMed ID: 16489000
    [Abstract] [Full Text] [Related]

  • 13. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
    Drikos I, Nounesis G, Vorgias CE.
    Proteins; 2009 Nov 01; 77(2):464-76. PubMed ID: 19452558
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA Damage.
    Wu W, Nishikawa H, Fukuda T, Vittal V, Asano M, Miyoshi Y, Klevit RE, Ohta T.
    Cancer Res; 2015 Apr 01; 75(7):1311-21. PubMed ID: 25634209
    [Abstract] [Full Text] [Related]

  • 16. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
    Fabbro M, Schuechner S, Au WW, Henderson BR.
    Exp Cell Res; 2004 Aug 15; 298(2):661-73. PubMed ID: 15265711
    [Abstract] [Full Text] [Related]

  • 17. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
    Ekblad CM, Friedler A, Veprintsev D, Weinberg RL, Itzhaki LS.
    Protein Sci; 2004 Mar 15; 13(3):617-25. PubMed ID: 14978302
    [Abstract] [Full Text] [Related]

  • 18. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.
    Ayi TC, Tsan JT, Hwang LY, Bowcock AM, Baer R.
    Oncogene; 1998 Oct 22; 17(16):2143-8. PubMed ID: 9798686
    [Abstract] [Full Text] [Related]

  • 19. Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms.
    Stewart MD, Duncan ED, Coronado E, DaRosa PA, Pruneda JN, Brzovic PS, Klevit RE.
    Protein Sci; 2017 Mar 22; 26(3):475-483. PubMed ID: 27977889
    [Abstract] [Full Text] [Related]

  • 20. BARD1 is an ATPase activating protein for OLA1.
    Chen T, Yeh HW, Chen PP, Huang WT, Wu CY, Liao TC, Lin SL, Chen YY, Lin KT, Hsu SD, Cheng HC.
    Biochim Biophys Acta Gen Subj; 2022 May 22; 1866(5):130099. PubMed ID: 35134491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.